Re: Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
Mera
Robertino
R
Fontham
Elizabeth T H
ET
Bravo
Luis E
LE
Bravo
Juan C
JC
Piazuelo
M Blanca
MB
Camargo
M Constanza
MC
Correa
Pelayo
P
D000975:Antioxidants / Q000627:therapeutic use; D004311:Double-Blind Method; D005163:Factor Analysis, Statistical; D005500:Follow-Up Studies; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications* / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D016015:Logistic Models; D015999:Multivariate Analysis; D018384:Oxidative Stress / Q000187:drug effects; D011230:Precancerous Conditions / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*
D000975:Antioxidants